These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 19646346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E, Ahlquist D, Ullrich S, Gross WL.
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG.
    Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
    [Abstract] [Full Text] [Related]

  • 6. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis.
    Bruner BF, Vista ES, Wynn DM, Harley JB, James JA.
    Clin Exp Immunol; 2010 Nov; 162(2):262-70. PubMed ID: 21077276
    [Abstract] [Full Text] [Related]

  • 7. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM, Oost-Kort W, Limburg PC, Specks U, Kallenberg CG.
    J Immunol Methods; 2000 Oct 20; 244(1-2):117-31. PubMed ID: 11033024
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
    Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, von dem Borne AE, Kallenberg CG, Goldschmeding R.
    Clin Exp Immunol; 1993 Sep 20; 93(3):405-10. PubMed ID: 8370167
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH.
    Arthritis Rheumatol; 2016 Dec 20; 68(12):2945-2952. PubMed ID: 27428559
    [Abstract] [Full Text] [Related]

  • 13. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
    Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG.
    Clin Exp Immunol; 1994 Dec 20; 98(3):448-53. PubMed ID: 7994909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
    Granel J, Korkmaz B, Nouar D, Weiss SAI, Jenne DE, Lemoine R, Hoarau C.
    Front Immunol; 2021 Dec 20; 12():571933. PubMed ID: 33679731
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1, and NOD2.
    Uehara A, Hirabayashi Y, Takada H.
    Clin Vaccine Immunol; 2008 Jul 20; 15(7):1060-6. PubMed ID: 18495849
    [Abstract] [Full Text] [Related]

  • 17. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B, Iking-Konert C, Schneider M, Andrassy K, Hänsch GM.
    Kidney Int; 2004 Sep 20; 66(3):1009-17. PubMed ID: 15327394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM, Tool AT, Videler J, de Haas M, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG, Roos D.
    Clin Exp Immunol; 2002 Sep 20; 129(3):562-70. PubMed ID: 12197900
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.